Yingcheng Yang

1.2k total citations
21 papers, 761 citations indexed

About

Yingcheng Yang is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Yingcheng Yang has authored 21 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 10 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Yingcheng Yang's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Yingcheng Yang is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Yingcheng Yang collaborates with scholars based in China, Germany and Ireland. Yingcheng Yang's co-authors include Lei Chen, Hongyang Wang, Li Tang, Xiaolan Yu, Jiyi Xia, Yong Cao, Bin Zhao, Yang Zhao, Fubo Ji and Xinyan Ji and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and SHILAP Revista de lepidopterología.

In The Last Decade

Yingcheng Yang

20 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingcheng Yang China 12 525 325 135 118 79 21 761
Junhe Li China 17 560 1.1× 342 1.1× 71 0.5× 172 1.5× 74 0.9× 31 795
Lifeng Liu China 18 708 1.3× 323 1.0× 68 0.5× 169 1.4× 87 1.1× 46 965
Peng Xiu China 17 385 0.7× 280 0.9× 151 1.1× 210 1.8× 62 0.8× 30 868
Xundi Xu China 13 424 0.8× 206 0.6× 61 0.5× 130 1.1× 48 0.6× 31 718
Sheng Zhou China 12 452 0.9× 380 1.2× 127 0.9× 135 1.1× 44 0.6× 20 748
Runping Fang China 18 733 1.4× 403 1.2× 82 0.6× 154 1.3× 82 1.0× 26 943
Junyu Cao China 16 513 1.0× 263 0.8× 74 0.5× 326 2.8× 81 1.0× 19 863
Peihua Wang China 13 451 0.9× 340 1.0× 89 0.7× 42 0.4× 57 0.7× 16 773

Countries citing papers authored by Yingcheng Yang

Since Specialization
Citations

This map shows the geographic impact of Yingcheng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingcheng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingcheng Yang more than expected).

Fields of papers citing papers by Yingcheng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingcheng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingcheng Yang. The network helps show where Yingcheng Yang may publish in the future.

Co-authorship network of co-authors of Yingcheng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yingcheng Yang. A scholar is included among the top collaborators of Yingcheng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingcheng Yang. Yingcheng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ye, Dezhan, Chenyi Wang, Yazhou Chen, et al.. (2024). Simultaneously catalyze 1,3-dioxolane polymerization and construct a hybrid protection layer on lithium anode by InF3 catalyst. Journal of Power Sources. 600. 234262–234262. 6 indexed citations
4.
Sun, Hui‐Chuan, Xiaodong Zhu, Kui Wang, et al.. (2024). Perioperative pembrolizumab and lenvatinib for resectable hepatocellular carcinoma: A single-arm, multi-center, phase II trial (NeoLEAP-HCC).. Journal of Clinical Oncology. 42(16_suppl). 4120–4120. 3 indexed citations
5.
Wang, Ting, Rui Huang, Xinyue Liu, et al.. (2024). Disruption of Ferroptosis Inhibition and Immune Evasion with Tumor‐Activatable Prodrug for Boosted Photodynamic/Chemotherapy Eradication of Drug‐Resistant Tumors. Advanced Healthcare Materials. 14(2). e2403473–e2403473. 8 indexed citations
6.
Pang, Shujie, Zhe Sun, Wenfeng Lu, et al.. (2022). Integrated Bioinformatics Analysis and Validation of the Prognostic Value of RBM10 Expression in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 2 indexed citations
7.
Pang, Shujie, Yang Shi, Dapeng Xu, et al.. (2022). Screening of Hepatocellular Carcinoma Patients with High Risk of Early Recurrence After Radical Hepatectomy Using a Nomogram Model Based on the γ-Glutamyl Transpeptidase-to-Albumin Ratio. Journal of Gastrointestinal Surgery. 26(8). 1619–1627. 3 indexed citations
8.
Wu, Tong, Yingcheng Yang, Bo Zheng, et al.. (2021). Distinct Immune Signatures in Peripheral Blood Predict Chemosensitivity in Intrahepatic Cholangiocarcinoma Patients. Engineering. 7(10). 1381–1392. 3 indexed citations
9.
Lü, Kai, Feiling Feng, Yingcheng Yang, et al.. (2019). High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma. Journal of Gastroenterology. 55(1). 51–66. 20 indexed citations
10.
Yang, Yingcheng, Xiaoping Tang, Xueqin Song, et al.. (2019). Evidence for an oncogenic role of HOXC6 in human non-small cell lung cancer. PeerJ. 7. e6629–e6629. 18 indexed citations
11.
Tang, Xiaoping, Yingcheng Yang, Xueqin Song, et al.. (2019). SIX4 acts as a master regulator of oncogenes that promotes tumorigenesis in non-small-cell lung cancer cells. Biochemical and Biophysical Research Communications. 516(3). 851–857. 19 indexed citations
12.
Ma, Xibo, Lei Chen, Yingcheng Yang, et al.. (2019). An Artificial Intelligent Signal Amplification System for in vivo Detection of miRNA. Frontiers in Bioengineering and Biotechnology. 7. 330–330. 3 indexed citations
13.
Yu, Xiaolan, Wei Tang, Yingcheng Yang, et al.. (2018). Long noncoding RNA NKILA enhances the anti-cancer effects of baicalein in hepatocellular carcinoma via the regulation of NF-κB signaling. Chemico-Biological Interactions. 285. 48–58. 60 indexed citations
14.
Yu, Xiaolan, et al.. (2018). Baicalein inhibits breast cancer growth via activating a novel isoform of the long noncoding RNA PAX8‐AS1‐N. Journal of Cellular Biochemistry. 119(8). 6842–6856. 43 indexed citations
15.
Guo, Xiaocan, Yang Zhao, Huan Yan, et al.. (2017). Single tumor-initiating cells evade immune clearance by recruiting type II macrophages. Genes & Development. 31(3). 247–259. 220 indexed citations
16.
Li, Meiyi, Chen Li, Weixin Liu, et al.. (2017). Dysfunction of PLA2G6 and CYP2C44-associated network signals imminent carcinogenesis from chronic inflammation to hepatocellular carcinoma. Journal of Molecular Cell Biology. 9(6). 489–503. 52 indexed citations
17.
Yu, Xiaolan, Yingcheng Yang, Yan Li, et al.. (2017). Baicalein inhibits cervical cancer progression via downregulating long noncoding RNA BDLNR and its downstream PI3 K/Akt pathway. The International Journal of Biochemistry & Cell Biology. 94. 107–118. 61 indexed citations
18.
Jiang, Feng, Lei Chen, Yingcheng Yang, et al.. (2015). CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling. Cancer Research. 75(7). 1470–1481. 52 indexed citations
19.
Tang, Jing, Liang Li, Wentao Huang, et al.. (2015). MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial–mesenchymal transition. Cancer Letters. 364(1). 33–43. 52 indexed citations
20.
Chang, Yan–Xin, Chen Liu, Jiahe Yang, et al.. (2013). miR-20a triggers metastasis of gallbladder carcinoma. Journal of Hepatology. 59(3). 518–527. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junhe Li Breakdown of academic impact, for papers by Lifeng Liu Breakdown of academic impact, for papers by Peng Xiu Breakdown of academic impact, for papers by Xundi Xu Breakdown of academic impact, for papers by Sheng Zhou Breakdown of academic impact, for papers by Runping Fang Breakdown of academic impact, for papers by Junyu Cao Breakdown of academic impact, for papers by Peihua Wang
Rankless by CCL
2026